QUANTITATIVE ASPECTS OF COMBINED INFUSIONAL 5-FU AND RADIATION IN ADVANCED CANCER

被引：0
|
作者：
BYFIELD, JE [1 ]
机构：
[1] UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103
来源：
BRITISH JOURNAL OF CANCER | 1981年 / 44卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：288 / 289
页数：2
相关论文
共 50 条
  • [1] Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
    Ducreux, M
    Mitry, E
    Ould-Kaci, M
    Boige, V
    Seitz, JF
    Bugat, R
    Breau, JL
    Bouchè, O
    Etienne, PL
    Tigaud, JM
    Morvan, F
    Cvitkovic, E
    Rougier, P
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 467 - 473
  • [2] Development of treatment for advanced colorectal cancer: Infusional 5-FU and the role of new agents
    Schmoll, HJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A : S18 - S22
  • [3] PROTRACTED INFUSIONAL 5-FLUOROURACIL (5-FU) AS NEOADJUVANT AND RADIATION SENSITIZOR IN GASTROINTESTINAL CANCER
    LOKICH, J
    RICH, T
    CHAFFEY, J
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 67 - 67
  • [4] Phase I trial of cisplatin, infusional 5-FU and irinotecan in advanced gastric cancer.
    Seguru, A
    Fernández-Martos, C
    Aparicio, J
    Campos, JM
    Vicent, J
    Busquier, I
    Molins, C
    Guillem, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 156S - 156S
  • [5] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [6] BIWEEKLY INFUSIONAL 5-FLUOROURACIL (5-FU) AND X-RAYS IN ADVANCED GASTROINTESTINAL CANCER (GICA)
    BYFIELD, JE
    BARONE, R
    SEAGREN, S
    FRANKEL, S
    QUINOL, L
    MENDELSOHN, J
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 322 - 322
  • [7] Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.
    Yamanaka H.
    Motohiro T.
    Michiura T.
    Asai A.
    Mori T.
    Hioki K.
    [J]. The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (10): : 943 - 948
  • [8] Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
    Gamelin, EC
    DanquechinDorval, EM
    Dumesnil, YF
    Maillart, PJ
    Goudier, MJ
    Burtin, PC
    Delva, RG
    Lortholary, AH
    Gesta, PH
    Larra, FG
    [J]. CANCER, 1996, 77 (03) : 441 - 451
  • [9] Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
    A Madi
    D Fisher
    R H Wilson
    R A Adams
    A M Meade
    S L Kenny
    L L Nichols
    M T Seymour
    H Wasan
    R Kaplan
    T S Maughan
    [J]. British Journal of Cancer, 2012, 107 : 1037 - 1043
  • [10] Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
    Madi, A.
    Fisher, D.
    Wilson, R. H.
    Adams, R. A.
    Meade, A. M.
    Kenny, S. L.
    Nichols, L. L.
    Seymour, M. T.
    Wasan, H.
    Kaplan, R.
    Maughan, T. S.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1037 - 1043
12345